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Introduction. The incidence of priapism in adults is higher than in children. Although approximately 50% of all episodes of
priapism are thought to be idiopathic, there are a number of known speciﬁc causes of this disorder. In adults intracavernous
therapy with papaverine, phentolamine, alprostadil or combinations of these agents is the most common cause of ischemic
priapism. In children the most common etiology is sickle cell anemia for low-ﬂow priapism or post-traumatic high-ﬂow priapism.
We present a 13-year-old boy, not sexually active presented to our outpatient clinic suﬀering from long standing (3.5 hours)
sustained painful erection. To the best of our knowledge the idiopathic low-ﬂow priapism in pre-pubertal boy was not reported
before in literature. Our case is the ﬁrst case to be reported in pre-pubertal age. Conclusion. In pre-pubertal boys idiopathic
recurrent priapism is a rare condition. In the literature, several empirical therapies are described. Recently, it is postulated that
a low dose of a PDE5 inhibitor. The early conservative management is the best treatment option to safe the corporeal smooth
muscles from irreversible damage.
Copyright © 2008 I. A. Hekal and E. J. H. Meuleman. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Priapism is deﬁned as involuntary prolonged penile erection
caused by factors other than sexual arousal. It is classiﬁed
into low ﬂow (ischemic or venous) or high ﬂow (nonis-
chemic or arterial).
The incidence of priapism in adults is higher than in
children. Although approximately 50% of all episodes of
priapism are thought to be idiopathic, there are a number
of known speciﬁc causes of this disorder. In adults, intracav-
ernous therapy with papaverine, phentolamine, alprostadil,
or combinations of these agents is the most common cause
of ischemic priapism [1]. In children, the most common
etiology is sickle cell anemia for low-ﬂow priapism or
posttraumatic high-ﬂow priapism [2].
To the best of our knowledge, the idiopathic low-ﬂow
priapism in prepubertal boy was not reported before in
literature. Our case is the ﬁrst case to be reported in
prepubertal age.
2. CASE REPORT
A 13-year-old boy, not sexually active, was presented to our
outpatient clinic suﬀering from long-standing (3.5 hours)
sustained painful erection. This condition was not preceded
by trauma nor drug intake. He had a history of three similar
attacksinthepast3monthsthatweremanagedbycavernosal
aspiration in another hospital. On examination, the penis
was erected with a soft glans. A trial with intracavernosal
aspiration under sedation and analysis of the aspirated blood
foroxygensaturationandPHwasdone:PH:7:01,PCo2:11.6
(arterial ref.: 4.5–6.1kPa), PO2: 3 (arterial ref.: 10–13.5kPa).
Laboratory investigation to rule out a haematologi-
cal disorder revealed normal blood picture (hemoglobin:
8.1m·mol/L (ref.: 7.4–10.3m·mol/L), RBCs: 4.62 × 1012/L
(ref.: 4.1–5.6 × 1012/L), WBCs: 5.6 × 109/L (ref.: 4.3–13.5 ×
109/L), and platelets: 195 × 109/L (ref.: 150–450 × 109/L).
Hemoglobin-S was negative. Although, based on these
results, a high-ﬂow priapism was unlikely, the presence of2 Advances in Urology
an arteriovenous ﬁstula was excluded by penile and perineal
duplex ultrasound.
Following cavernosal aspiration under sedation, the
penis became ﬂaccid and the boy was discharged from
admission. Physical exercise and oral-low dose of acetylsal-
icylate (40mg) and ice packs were recommended in case the
priapism would recur at home.
One week later, the boy came for a followup visit. On
examination, his penis was ﬂaccid with an ecchymotic patch
at the aspiration puncture site. He reported to have morning
erections. He was advised to continue the conservative
management with low dose of acetylsalicylate (40mg).
3. DISCUSSION
Priapism is a condition ﬁrst described by Tripe in 1845
[3]. It has been deﬁned as a pathological condition of
penile erection that persists beyond or is unrelated to sexual
stimulation [4].
In children and prepubertal boys as well as in adults,
it can be classiﬁed according to the aetiology into low-ﬂow
(ischemic) and high-ﬂow priapism. Most common causes
of the former are the use of medications and hematological
conditions. Several medications have been implicated in
ischemic priapism. Most notably, psychiatric drugs as a class
areoverrepresented.Antipsychoticssuchaschlorpromazine,
phenothiazine, and clozapine are known culprits as well are
the antidepressants such as trazodone [5]. Olanzapine or
methylphenidate therapy (drugs used for attention deﬁcit
hyperactivity disorder) is reported to cause priapism in
children [6]. Total parenteral nutrition, with its high fat
content,isalsobelievedtocausepriapism[7].Hematological
diseases that are accompanied by hyperviscosity such as
sicklecelldiseaseortraitandleukemiaarewell-knowncauses
of ischemic priapism in children [8].
High-ﬂow (nonischemic) priapism was ﬁrstly described
over40yearsago[9].Itisalwaystheresultofastraddleinjury
of the corpora cavernosal resulting in an arteriocavernosal
ﬁstula, which on its turn results in an uncontrolled arterial
inﬂow into the cavernosal sinusoids. Because the cavernosal
smooth muscle is contracted and well oxygenated (on
aspiration,brightredbloodwithahighPO2isencountered),
the erection is semirigid and not painful [8]. Gold standard
in the diagnosis of high-ﬂow priapism is the demonstration
of turbulent blood ﬂow through the arteriocavernosal ﬁstula
with the aid of perineal colour Doppler ﬂowmetry [10, 11].
The treatment of choice is highly selective embolisation of
the aﬀected cavernosal artery with gel foam or an autologous
blood clot [8].
In low-ﬂow priapism, venous outﬂow is blocked due
to a complete paralysis of the cavernous smooth muscle.
Due to ischemia, the erection is painful. One aspiration
dark blood (with an acidic PH and low P02) is found.
Primary treatment consists of cavernosal aspiration and
corporal rinsing with norepinephrine or methylene blue.
When the priapism appears to be resistant to this ﬁrst
line treatment, a surgical shunting procedure designed to
improve penile venous drainage can be performed. This
will only be successful if a frozen section of a cavernosal
biopsy has shown the existence of vital cavernosal smooth
muscle tissue. In case of necrosis, a shunting procedure is
likely to fail, and implantation of an erection prosthesis
to prevent penile future ﬁbrosis and shortening may be
warranted (personal communication). Thus, the corporeal
frozen section could be an option for clinical decision-
making and opposed to the standard shunting then awaiting
clinical result before placement of prosthesis.
Various histological studies have been performed to
deﬁne the histological changes in relation with the duration
of ischemia. In the early stages at less than 12 hours,
interstitial edema and thickening are the most common
ﬁndings. From 12 to 24 hours, thrombocytes start to adhere
to the endothelium such that by 48 hours necrosis of
cavernosal smooth muscle cells and ﬁbroblast proliferation
has occurred. The end result is loss of smooth muscle and
ﬁbrosis of the corpora cavernosa [12].
Low-ﬂow priapism has been described in men of all ages
including newborns. The peak incidence is bimodal with the
highest incidence occurring between the ages of 5–10, and
20–50 years. Generally in the younger age group, priapism is
secondary to a neoplasm or sickle cell anemia [8].
The main causeof priapism in children is haematological
disorders:mostnotablysicklecelldiseaseoracuteleukaemia.
In these conditions, priapism may be associated with general
signs and symptoms of, for example, a sickle cell crisis
involving other areas of the body. However, very often it
presents as an isolated event [13]. Initial treatment should
be aimed at the systemic management of the underlying
condition (e.g., in sickle cell disease, rapid hydration exists
with IV ﬂuids between two to three times in the maintenance
rate) and analgesia with meperidine or morphine, and hyper
transfusion with packed red blood cells to increase the
h e m o gl o b i nt oa b o v e1 0t o1 2m gpe rdl[ 14]. Furthermore, a
trialofcorporalaspirationandinstillationofnorepinephrine
should be attempted. Fortunately, most cases of sickle cell
priapism in children resolve promptly with these measures.
However, if this fails and the penis remains erect and painful
longer then 6 hours, more aggressive surgical management
with glandular corporal or spongiocorporal shunt may be
required [15]. This can be eﬀective up to 24–48 hours
after the onset of the priapism, depending on the result
of the frozen section of cavernous smooth muscle tissue
[10]. Should priapism recur after the initial episode? The
condition is called stuttering or recurrent priapism [16–
18].Thepathophysiologyofstutteringpriapismisunknown.
It is speculated that downregulation of adrenoreceptors in
the cavernous smooth musculature or scarring of intra-
cavernous venules may trigger the recurrences [8]. In the
literature, several empirical treatments are advocated to
prevent recurrences, such as low-dose aspirin and digitalis.
Recently, Burnett et al. postulated that glucose-6-phosphate
dehydrogenase deﬁciency (G6PD deﬁciency) may oﬀer an
explanation for idiopathic priapism. They observed that
priapism recurrences were suﬃciently resolved with low-
dose PDE5 inhibitor therapy and explain this observation by
the fact that G6PD deﬁciency generates a pathophysiologic
milieu consistent with aberrant nitric oxide (NO)-signallingI. A. Hekal and E. J. H. Meuleman 3
and heightened oxidative stress in the corpus cavernosum
[19].
In general, treatment is aimed at the primary cause of
the priapism if it can be identiﬁed. The ultimate goal of
treatment is to relieve the pain and stop the erection to
prevent damage to the corporal bodies.
4. CONCLUSION
In prepubertal boys, idiopathic recurrent priapism is a rare
condition. In the literature, several empirical therapies are
described.Recently,itispostulatedthatglucose-6-phosphate
dehydrogenase deﬁciency may oﬀer an explanation for the
pathophysiological mechanism and that the condition may
be resolved with a low dose of a PDE5 inhibitor.
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